Robert W. Baird Reconfirms a “Hold” Rating on Biogen (BIIB) and $323.0 Target; Linden Advisors ...

Retrieved on: 2018-01-25 02:22:30

Tags for this article:

Business

Economy

Spinal muscular atrophy

Monoclonal antibodies

Click the tags to see associated articles and topics

Robert W. Baird Reconfirms a “Hold” Rating on Biogen (BIIB) and $323.0 Target; Linden Advisors .... View article details on hiswai:

Excerpt

<div>Linden Advisors Lp decreased <b>Infosys</b> Tech (INFY) stake by 83.83% reported in 2017Q3 SEC filing. Linden Advisors Lp sold 251,476 shares as <b>Infosys</b> Tech (INFY)'s stock rose 1.88%. The Linden Advisors Lp holds 48,524 shares with $708,000 value, down from 300,000 last quarter. <b>Infosys</b> Tech now ...</div>

Article found on:

View Original Article